Health · 45 views
Focal therapy use remains uncommon in nonmetastatic prostate cancer
For patients with nonmetastatic prostate cancer, focal therapy use has remained uncommon across risk groups, and its use was defined as inappropriate in about half of recipients, according to a research letter published online Aug. 13 in…
AI Summary
A retrospective analysis of the National Cancer Database found that focal therapy remains rarely used for U.S. patients aged 50 and older with nonmetastatic prostate cancer diagnosed between 2010 and 2023. The study, led by Andrea Cosenza, M.D., reported that roughly half of the patients who did receive focal therapy were classified as receiving it inappropriately, regardless of whether their disease was low, high, or very high risk. The findings were published as a research letter in JAMA on August 13.
AI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedMore from Health
Continue reading recent Health coverage
- Injectable glucose sensor component matches pricier alternative at one-tenth the costContinue reading
- Brain Injury Creates Musical Genius; Long COVID Improvement; Dementia and DeliriumContinue reading
- Cool Temps and HF; Death After On-Field Collision; Shave and Shake in StentingContinue reading
- A possible chemical explanation for why we give up on tough tasksContinue reading
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow